Sippican Capital Advisors Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Columbia Banking Systems
COLB
|
+$1.15M |
| 2 |
3M
MMM
|
+$886K |
| 3 |
Healthpeak Properties
DOC
|
+$664K |
| 4 |
MOFG
MidWestOne Financial Group
MOFG
|
+$468K |
| 5 |
Pfizer
PFE
|
+$406K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$1.33M |
| 2 |
JPMorgan Chase
JPM
|
+$871K |
| 3 |
Eli Lilly
LLY
|
+$776K |
| 4 |
CATC
CAMBRIDGE BANCORP
CATC
|
+$628K |
| 5 |
DaVita
DVA
|
+$539K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 30.92% |
| 2 | Healthcare | 15.99% |
| 3 | Energy | 14.58% |
| 4 | Consumer Discretionary | 10.93% |
| 5 | Industrials | 10.8% |
Similar funds
Sippican Capital Advisors's Q1 2024 Portfolio in Review
As of Q1 2024, Sippican Capital Advisors held 122 positions worth $129M, up 0.86% from $127M the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Sippican Capital Advisors withdrew a net $8.51M in Q1 2024, closing 8 positions and reducing 65 holdings. Its most notable exit was PHYSICIANS REALTY TRUST, an estimated $516K position sold in full.
By sector, the portfolio is most concentrated in Financials at 31% of assets, down from 32% a quarter earlier, followed by Healthcare and Energy.
Against the trend, Sippican Capital Advisors opened a new position in Healthpeak Properties worth $686K.
- Sippican Capital Advisors's largest Q1 2024 buy was Healthpeak Properties: 36,564 shares worth $686K.
- Sippican Capital Advisors added most to Columbia Banking Systems in Q1 2024, an estimated $1.15M increase.
- Sippican Capital Advisors's biggest Q1 2024 reduction was Gilead Sciences, cutting an estimated $1.33M.
- Sippican Capital Advisors fully exited PHYSICIANS REALTY TRUST in Q1 2024, selling an estimated $516K.
- Sippican Capital Advisors's ten largest holdings make up 26% of its $129M portfolio in Q1 2024.
- Sippican Capital Advisors opened 5 new positions and closed 8 in Q1 2024.
- Sippican Capital Advisors's portfolio value rose 0.86% quarter-over-quarter to $129M.
Based on Sippican Capital Advisors's 13F filing for Q1 2024, filed 2 May 2024.